CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use

AIDS. 2004 Nov 5;18(16):2210-2. doi: 10.1097/00002030-200411050-00018.

Abstract

We evaluated the impact of HIV risk practice on immune reconstitution in a prospective cohort of 288 patients (176 former injecting drug users) who maintained complete virus suppression for more than 24 months. Significant differences in CD4 cell counts at 6 and 24 months were detected. Multivariate analysis showed that drug use was an independent predictor of poor immunological recovery. Injection drug abuse impairs short and long-term CD4 cell recovery in HIV-positive patients initiating successful highly active antiretroviral therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV-1*
  • Humans
  • Male
  • Multivariate Analysis
  • Substance Abuse, Intravenous*
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-HIV Agents